Antibody Therapeutics Patients First!

공지사항


번호 제목 작성자 작성일 조회
45   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the company presentation session at BIO 2018.   관리자   2018-08-06   30,155  
44   PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme.   관리자   2018-08-06   20,189  
43   `` Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model`` is now indexed on PubMed.   관리자   2018-08-06   8,227  
42   ``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2`` is now indexed on PubMed.   관리자   2018-08-06   890  
41   Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.   관리자   2018-08-06   5,349  
40   Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.   관리자   2018-08-06   1,709  
39   Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at BOSTON CEO on May 10th, 2018.   관리자   2018-08-06   12,087  
38   PharmAbcine was introduced today in The South China Morning Post-2018 South Korea Business Report.   관리자   2018-08-06   852  
37   Job Opportunities_Senior Research Associate with cancer immunology background   관리자   2018-08-06   7,700  
36   Job Opportunities_Senior Research Associate with expertise in designing PK analysis study and QC/QA   관리자   2018-08-06   14,170